Englander Institute for Precision Medicine

Publications

Found 790 results
Author Title Type [ Year(Asc)]
2019
Rubin MA, Demichelis F.  2019.  The Genomics of Prostate Cancer: A Historic Perspective.. Cold Spring Harb Perspect Med. 9(3)
Musselman K, Glynn S, Mosquera JMiguel, Elemento O, Sboner A, Beltran H, Holcomb K.  2019.  Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma.. Gynecol Oncol Rep. 28:54-57.
Liu EMinwei, Martinez-Fundichely A, Diaz BJay, Aronson B, Cuykendall T, MacKay M, Dhingra P, Wong EWP, Chi P, Apostolou E et al..  2019.  Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes.. Cell Syst. 8(5):446-455.e8.
Mosquera MJ, Kim S, Zhou H, Jing TT, Luna M, Guss JD, Reddy P, Lai K, Leifer CA, Brito IL et al..  2019.  Immunomodulatory nanogels overcome restricted immunity in a murine model of gut microbiome-mediated metabolic syndrome.. Sci Adv. 5(3):eaav9788.
Pederzoli F, Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN et al..  2019.  Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.. Eur Urol. 76(4):425-429.
Holyoak DT, Wheeler TA, van der Meulen MCH, Singh A.  2019.  Injectable mechanical pillows for attenuation of load-induced post-traumatic osteoarthritis.. Regen Biomater. 6(4):211-219.
Chu SH, Huang M, Kelly RS, Benedetti E, Siddiqui JK, Zeleznik OA, Pereira A, Herrington D, Wheelock CE, Krumsiek J et al..  2019.  Integration of Metabolomic and Other Omics Data in Population-Based Study Designs: An Epidemiological Perspective.. Metabolites. 9(6)
Mueller FB, Yang H, Lubetzky M, Verma A, Lee JR, Dadhania DM, Xiang JZ, Salvatore SP, Seshan SV, Sharma VK et al..  2019.  Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.. JCI Insight. 4(13)
Halama A, Kahal H, Bhagwat AM, Zierer J, Sathyapalan T, Graumann J, Suhre K, Atkin SL.  2019.  Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes.. Diabetes Obes Metab. 21(4):909-919.
Playdon MC, Joshi AD, Tabung FK, Cheng S, Henglin M, Kim A, Lin T, van Roekel EH, Huang J, Krumsiek J et al..  2019.  Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS).. Metabolites. 9(7)
Danko DC, Meleshko D, Bezdan D, Mason C, Hajirasouliha I.  2019.  Minerva: an alignment- and reference-free approach to deconvolve Linked-Reads for metagenomics.. Genome Res. 29(1):116-124.
Gilvary C, Madhukar N, Elkhader J, Elemento O.  2019.  The Missing Pieces of Artificial Intelligence in Medicine.. Trends Pharmacol Sci. 40(8):555-564.
Do KTrinh, Rasp DJN-P, Kastenmüller G, Suhre K, Krumsiek J.  2019.  MoDentify: phenotype-driven module identification in metabolomics networks at different resolutions.. Bioinformatics. 35(3):532-534.
Kim S, Shah SB, Graney PL, Singh A.  2019.  Multiscale engineering of immune cells and lymphoid organs.. Nat Rev Mater. 4(6):355-378.
Puca L, Vlachostergios PJ, Beltran H.  2019.  Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.. Cold Spring Harb Perspect Med. 9(2)
Ghandi M, Huang FW, Jané-Valbuena J, Kryukov GV, Lo CC, E McDonald R, Barretina J, Gelfand ET, Bielski CM, Li H et al..  2019.  Next-generation characterization of the Cancer Cell Line Encyclopedia.. Nature. 569(7757):503-508.
Berger A, Brady NJ, Bareja R, Robinson B, Conteduca V, Augello MA, Puca L, Ahmed A, Dardenne E, Lu X et al..  2019.  N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.. J Clin Invest. 129(9):3924-3940.
Zacharias HU, Altenbuchinger M, Schultheiss UT, Samol C, Kotsis F, Poguntke I, Sekula P, Krumsiek J, Köttgen A, Spang R et al..  2019.  A Novel Metabolic Signature To Predict the Requirement of Dialysis or Renal Transplantation in Patients with Chronic Kidney Disease.. J Proteome Res. 18(4):1796-1805.
Springer NL, Iyengar NM, Bareja R, Verma A, Jochelson MS, Giri DD, Zhou XK, Elemento O, Dannenberg AJ, Fischbach C.  2019.  Obesity-Associated Extracellular Matrix Remodeling Promotes a Macrophage Phenotype Similar to Tumor-Associated Macrophages.. Am J Pathol. 189(10):2019-2035.
Karass M, Bareja R, Shelkey E, Vlachostergios PJ, Robinson BD, Khani F, Mosquera JMiguel, Scherr DS, Sboner A, Tagawa ST et al..  2019.  Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.. J Natl Compr Canc Netw. 17(3):194-200.
Sivakumar R, Chan M, Shin JStella, Nishida-Aoki N, Kenerson HL, Elemento O, Beltran H, Yeung R, Gujral TS.  2019.  Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery.. Oncoimmunology. 8(12):e1670019.
Liu B, Li L, Yang G, Geng C, Luo Y, Wu W, Manyam GC, Korentzelos D, Park S, Tang Z et al..  2019.  PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.. Clin Cancer Res. 25(22):6839-6851.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Malikic S, Mehrabadi FRashidi, Ciccolella S, Rahman MKhaledur, Ricketts C, Haghshenas E, Seidman D, Hach F, Hajirasouliha I, S Sahinalp C.  2019.  PhISCS: a combinatorial approach for subperfect tumor phylogeny reconstruction via integrative use of single-cell and bulk sequencing data.. Genome Res. 29(11):1860-1877.
Jayaram A, Wingate A, Wetterskog D, Conteduca V, Khalaf D, Sharabiani MTaghavi Az, Calabrò F, Barwell L, Feyerabend S, Grande E et al..  2019.  Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.. JCO Precis Oncol. 3